From Shrimp Shells to Seaweed: Marine Biopolymers Emerge as Nutraceutical Powerhouses

The ocean has quietly become one of the most promising pharmacies for functional food science, and a sweeping new review published in Polymer Bulletin suggests that the next generation of nutraceuticals may be pulled not from synthetic chemistry but from the discarded shells of shrimp, the cell walls of seaweeds, and the skins of fish that processing plants would otherwise throw away. The review, led by Faisal Rashid Sofi of the Sher-E-Kashmir University of Agricultural Sciences and Technology of Kashmir together with an international team of fisheries and food scientists, systematically examines eight major classes of marine-derived biopolymers: chitin and its deacetylated derivative chitosan, agar, carrageenan, alginate, marine cellulose, ulvan, collagen, and gelatin. For each, the authors assess where the material comes from, how it can be extracted, what functional and biological properties it carries, and critically, how much of the claimed health potential has actually been validated in humans.

The sheer diversity of these materials is striking. Chitin, the second most abundant biopolymer on Earth after cellulose, forms the structural skeleton of crustacean shells and fungal cell walls. When its acetyl groups are stripped away through deacetylation, it becomes chitosan, a positively charged polysaccharide whose amine groups give it antimicrobial activity, mucoadhesive behavior, and the ability to form gels, films, and nanoparticles. Agar and carrageenan, both sulfated or galactan-based polysaccharides extracted from red seaweeds, are already familiar workhorses of the food industry as gelling and thickening agents. Alginate, harvested from brown seaweeds, is famous for its ability to form stable hydrogels through the so-called egg-box model, in which divalent calcium ions bridge guluronic acid blocks on adjacent polymer chains. Ulvan, extracted from green seaweeds of the genus Ulva, remains comparatively obscure but carries sulfate groups and uronic acids that have attracted attention for immunomodulatory activity. Collagen and gelatin, meanwhile, come largely from fish skins, scales, and bones, offering an alternative to bovine and porcine sources that sidesteps both religious dietary restrictions and concerns about bovine spongiform encephalopathy.

One of the review’s most valuable contributions is its honest accounting of extraction yields, which vary enormously depending on both the source organism and the processing route. The authors report that chitosan-containing shrimp-shell residue yielded just 10.56 percent in one process, while chitosan extracted from mixed fishery waste reached 20.45 percent. Alginate from selected brown seaweeds delivered yields between 29.28 and 30.9 percent, agar from the red alga Gracilaria corticata ranged from 20.91 to 33 percent, and collagen from the skin of the Amazonian freshwater fish pirarucu came in at 27.8 percent. These numbers matter because yield, purity, and molecular weight collectively determine whether a marine biopolymer can be produced economically at industrial scale. A process that recovers a third of the available polymer is a very different commercial proposition from one that recovers a tenth, and the review makes clear that no single extraction protocol has yet emerged as the standard.

That variability is driving a wave of innovation in green extraction technology. Traditional chitin production relies on harsh mineral acid demineralization and alkaline deproteinization, generating significant chemical waste. Newer approaches replace or supplement these steps with ultrasound-assisted processing, subcritical water hydrolysis, supercritical carbon dioxide, and even ionic liquids that can dissolve chitin directly and allow deproteinization under milder conditions. Agar recovery has been boosted by combining subcritical water extraction with moderate electric fields, while collagen has been pulled from marine sponges and Atlantic cod skins using nothing more aggressive than water acidified with carbon dioxide. These techniques promise lower environmental footprints, better preservation of heat-sensitive bioactivity, and in some cases improved thermal stability and water-holding capacity in the final product, properties that matter enormously when the polymer is destined for a food matrix rather than a laboratory beaker.

The biological activities attributed to these polymers form the scientific heart of the nutraceutical case. Chitosan and its oligomers display broad-spectrum antibacterial activity, thought to arise from the electrostatic interaction between the polymer’s protonated amine groups and the negatively charged membranes of bacterial cells, disrupting permeability and ultimately killing the microbe. Chitosan has also been shown in animal models to ameliorate chemically induced ulcerative colitis by strengthening the intestinal barrier and reshaping the gut microbiome. Carrageenan fragments, particularly low-molecular-weight kappa-carrageenan hexamers, have demonstrated anti-inflammatory effects in macrophage cell lines by inhibiting the CD14 receptor pathway. Fucoidan, a sulfated polysaccharide from brown seaweeds, has activated natural killer cells in mice and reduced the viability of lung carcinoma and melanoma cells in vitro. Alginate acts as a soluble dietary fiber that slows gastric emptying and blunts postprandial glycemic spikes, an effect documented in humans with diabetes as early as the 1990s. Neoagaro-oligosaccharides derived from enzymatic hydrolysis of agarose show prebiotic effects, feeding beneficial anaerobic gut bacteria.

Yet the review is refreshingly blunt about the gap between laboratory promise and clinical proof. Recent human evidence genuinely supports the oral use of fish-derived collagen peptides, with clinical studies reporting improvements in skin elasticity, cellulite severity, and hair shaft diameter, supported by pharmacokinetic data showing that orally administered low-molecular-weight collagen peptides are absorbed and circulate in the bloodstream. Beyond collagen, however, most of the headline-grabbing health effects remain preclinical. Chitosan-alginate delivery systems, for example, have shown impressive results in animal models of inflammatory bowel disease, where colon-targeted microspheres co-delivering synbiotics and nanozymes ameliorated disease symptoms, and in controlled-release systems for antidiabetic peptides derived from rapeseed. But these are mouse and cell studies, not double-blind human trials. Similarly, the immunostimulatory effects of fucoidan on dendritic cells and the fat-binding claims once made for chitosan weight-loss supplements have not been translated into robust human evidence, and a controlled trial of chitosan supplementation in men and women found no significant effect on fat absorption.

Where marine biopolymers may have their most immediate practical impact is as delivery vehicles rather than as active ingredients themselves. Because alginates gel gently in the presence of calcium and chitosan is mucoadhesive and forms polyelectrolyte complexes with anionic polymers, the two are natural partners for encapsulation. The review describes alginate-membrane-modified nanochitosomes that stabilize apricot kernel-derived peptides with ACE-inhibitory activity, chitosan-alginate nanocarriers that control the release of therapeutic peptides, and alginate hydrogels used in everything from wound dressings to 3D bioprinting scaffolds. Encapsulation protects sensitive bioactive compounds from degradation in the stomach, masks undesirable flavors, and can be engineered to release payloads only when they reach the intestine, where absorption is most favorable. This carrier function may prove to be the bridge that carries marine biopolymers into commercial nutraceutical products even while their direct health effects await clinical confirmation.

Safety and standardization emerge as the review’s central caveats. Extraction yields that swing by a factor of three between studies signal a field that has not converged on reproducible manufacturing. Contaminant control is a genuine concern for any marine-derived ingredient, since shellfish waste and seaweeds can concentrate heavy metals, persistent organic pollutants, and pathogenic microbes from their environment. The authors also note lingering scientific debate around degraded carrageenan and inflammatory effects reported in some animal studies, underscoring the need for careful molecular-weight characterization and food safety assessment before new applications reach consumers. Their prescription is straightforward but demanding: standardized extraction and characterization protocols, rigorous contaminant screening, formal food safety evaluation, and, above all, well-designed randomized human trials to replace the current patchwork of in vitro and animal findings.

Even with those caveats, the trajectory is unmistakable. Global seafood processing generates millions of tonnes of shells, skins, bones, and heads every year, most of which are discarded or sold as low-value animal feed, and seaweed farming is expanding rapidly as a sustainable source of biomass that requires no freshwater, fertilizer, or arable land. Converting this waste stream into chitosan, collagen, alginate, and agar represents exactly the kind of circular bioeconomy that food systems worldwide are scrambling to build. The review’s authors conclude that marine biopolymers show considerable nutraceutical potential, and the evidence they assemble supports that verdict, provided the field resists the temptation to oversell preclinical results. If the coming decade delivers the standardized processes and human trials the authors call for, the humble shrimp shell and the lowly green seaweed may find themselves among the most valuable raw materials in functional food science, transforming what was once waste into the backbone of a new generation of ocean-derived health products.

Subject of Research: Marine-derived biopolymers and their potential applications as nutraceuticals

Article Title: Marine-derived biopolymers – the wider prospects as nutraceuticals

Article References: Sofi, F. R., Kumar, L. R. G., Sannejal, A. D., Aakila, Manjunatha, K. G., Surasani, V. K. R., Behere, G. S., Saba, K., Maqbool, H., Hussain, T., & Pathak, N. (2026). Marine-derived biopolymers – the wider prospects as nutraceuticals. Polymer Bulletin, 83(12), Article 650. https://doi.org/10.1007/s00289-026-06696-9

Image Credits: AI Generated

DOI: 10.1007/s00289-026-06696-9

Keywords: marine biopolymers, nutraceuticals, chitosan, alginate, collagen, gelatin, agar, carrageenan, ulvan, green extraction, functional foods, fishery waste valorization